{% raw %}<table class="grid">
<tbody>
<tr><td>Defining URL:</td><td>http://fhir.nmdp.org/ig/cibmtr-reporting/StructureDefinition/cibmtr-additional-peri-transplant-medication</td></tr>
 <tr><td>Version:</td><td>0.1.8</td></tr>
 <tr><td>Name:</td><td>CIBMTR_AdditionalPeriTransplantMedication</td></tr>
 <tr><td>Title:</td><td>CIBMTR Additional Drugs in Peri-Transplant Period</td></tr>
 <tr><td>Status:</td><td>Draft as of 2025-02-18 15:55:04-0600</td></tr>
 <tr><td>Definition:</td><td><p>CIBMTR Additional Drugs Given in the Peri-Transplant Period. Drugs may be given during the peri-transplant period to prevent transplant-related complications, such as liver injuries or to facilitate engraftment.</p>
</td></tr>
 <tr><td>Publisher:</td><td>The Medical College of Wisconsin, Inc. and the National Marrow Donor Program. <a href="http://www.cibmtr.org">The Medical College of Wisconsin, Inc. and the National Marrow Donor Program</a>, . , <a href="mailto:bmilius@nmdp.org">Email</a></td></tr>
 <tr><td>Source Resource:</td><td><a href="StructureDefinition-cibmtr-additional-peri-transplant-medication.profile.xml.html">XML</a> / <a href="StructureDefinition-cibmtr-additional-peri-transplant-medication.profile.json.html">JSON</a> / <a href="StructureDefinition-cibmtr-additional-peri-transplant-medication.profile.ttl.html">Turtle</a></td></tr>
</tbody></table>
{% endraw %}